Solid Biosciences Inc. Common Stock (SLDB) Stock Price

SLDBStock

$9.89+54.47%52W

Market Cap$1.06B

P/E—

PEG Ratio—

Div yield—

Beta2.42

SLDB Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)43.48%

Price vs S&P 500 (4W)11.88%

VGM Score55.59

Book Value / Share (Quarterly)$3.56

P/TBV (Annual)0.27x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-1.79

Price vs S&P 500 (YTD)50.45%

Net Profit Margin (TTM)-588.30%

EPS (TTM)$-1.91

10-Day Avg Trading Volume0.87M

EPS Excl Extra (TTM)$-1.91

EPS (Annual)$-3.05

ROI (Annual)-90.27%

Net Profit Margin (5Y Avg)-2019.34%

Cash / Share (Quarterly)$3.59

ROA (Last FY)-66.26%

EBITD / Share (TTM)$-1.90

ROE (5Y Avg)-61.82%

Operating Margin (TTM)-591.14%

Cash Flow / Share (Annual)$-1.99

P/B Ratio2.61x

P/B Ratio (Quarterly)2.63x

Net Income / Employee (Annual)$-1,033,100

EV / Revenue (TTM)55.27x

Net Interest Coverage (TTM)-65.60x

ROA (TTM)-61.37%

EPS Incl Extra (Annual)$-3.05

Current Ratio (Annual)6.14x

Quick Ratio (Quarterly)13.24x

3-Month Avg Trading Volume1.45M

52-Week Price Return54.47%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$7.20

P/S Ratio (Annual)120.74x

Asset Turnover (Annual)0.03x

52-Week High$11.45

Operating Margin (5Y Avg)-2044.22%

EPS Excl Extra (Annual)$-3.05

CapEx CAGR (5Y)5.08%

Tangible BV CAGR (5Y)26.66%

26-Week Price Return54.73%

Quick Ratio (Annual)5.65x

13-Week Price Return40.92%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)13.82x

Enterprise Value$817.43M

Asset Turnover (TTM)0.07x

Book Value / Share Growth (5Y)-37.11%

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-1062.79%

Cash / Share (Annual)$2.38

3-Month Return Std Dev67.43%

Net Income / Employee (TTM)$-1,711,600

ROE (Last FY)-91.08%

Net Interest Coverage (Annual)-81.57x

EPS Basic Excl Extra (Annual)$-3.05

Receivables Turnover (TTM)162.00x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.91

Receivables Turnover (Annual)147.16x

ROI (TTM)-72.26%

P/S Ratio (TTM)66.05x

Pretax Margin (5Y Avg)-2019.34%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$10.82

Price vs S&P 500 (52W)36.16%

Year-to-Date Return62.41%

5-Day Price Return0.88%

EPS Normalized (Annual)$-3.05

ROA (5Y Avg)-48.03%

Net Profit Margin (Annual)-1062.79%

Month-to-Date Return13.65%

Cash Flow / Share (TTM)$-4.97

EBITD / Share (Annual)$-3.11

Operating Margin (Annual)-1090.48%

LT Debt / Equity (Annual)0.80x

ROI (5Y Avg)-61.28%

LT Debt / Equity (Quarterly)0.94x

EPS Basic Excl Extra (TTM)$-1.91

P/TBV (Quarterly)0.39x

P/B Ratio (Annual)2.44x

Pretax Margin (TTM)-588.30%

Book Value / Share (Annual)$2.28

Price vs S&P 500 (13W)38.13%

Beta2.42x

Revenue / Share (TTM)$0.00

ROE (TTM)-72.28%

52-Week Low$3.79

vGradeD

mGradeB

vgmGradeC

SLDB Earnings Surprise History

Q2 25-0.42est. -0.49

Q3 25-0.48est. -0.44

Q4 25-0.53est. -0.52

Q2 26-0.38est. -0.47

SLDB Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.35

4.37

Industry Peers — Biological Products(183)

Symbol	Value Score	Growth Score	Momentum Score	Price
SLDBSolid Biosciences Inc. Common Stock	D	—	B	$9.89
AMGNAmgen Inc	C	C	B	$442.24
GILDGilead Sciences Inc	C	B	B	$148.77
MRNAModerna, Inc. Common Stock	D	C	A	$158.83
ARGXargenx SE American Depositary Shares	D	A	B	$1019.49
RVMDRevolution Medicines, Inc. Common Stock	F	—	A	$211.38
BIIBBiogen Inc. Common Stock	C	D	B	$220.77
BNTXBioNTech SE American Depositary Share	C	C	B	$114.05
NBIXNeurocrine Biosciences Inc	C	B	C	$153.37
EXELExelixis Inc	C	B	B	$56.72
HALOHalozyme Therapeutics, Inc.	C	B	A	$109.32
TECHBio-Techne Corp.	D	C	B	$72.33
KRYSKrystal Biotech, Inc. Common Stock	D	B	B	$356.19
KYMRKymera Therapeutics, Inc. Common Stock	D	B	B	$126.64
RGENRepligen Corp	D	C	A	$181.69
APGEApogee Therapeutics, Inc. Common Stock	—	—	A	$134.85
TWSTTwist Bioscience Corporation Common Stock	D	B	A	$151.42
PCVXVaxcyte, Inc. Common Stock	—	—	B	$61.09
QGENQIAGEN N.V.	C	C	C	$43.65
IMVTImmunovant, Inc. Common Stock	—	—	B	$43.50
IBRXImmunityBio, Inc. Common Stock	F	A	C	$8.19
SRRKScholar Rock Holding Corporation Common Stock	F	—	B	$58.25
CGONCG Oncology, Inc. Common stock	F	A	A	$78.95
CRSPCRISPR Therapeutics AG	D	B	B	$60.90
RLAYRelay Therapeutics, Inc. Common Stock	F	D	A	$20.57
ADPTAdaptive Biotechnologies Corporation Common Stock	D	B	A	$26.25
DNLIDenali Therapeutics Inc. Common Stock	F	—	B	$24.93
IOVAIovance Biotherapeutics, Inc. Common Stock	C	B	A	$8.44
BEAMBeam Therapeutics Inc. Common Stock	C	B	B	$31.03
TARSTarsus Pharmaceuticals, Inc. Common Stock	D	A	B	$71.45
BCRXBioCryst Pharmaceuticals Inc	B	A	B	$9.83
KODKodiak Sciences Inc Common Stock	—	—	B	$39.46
COAGHemab Therapeutics Holdings, Inc. Common Stock	—	—	B	$49.65
MESOMesoblast Limited American Depositary Shares	D	B	C	$17.19
VCELVericel Corporation	D	B	C	$43.22
ADMAADMA Biologics, Inc.	C	C	C	$9.72
TSHATaysha Gene Therapies, Inc. Common Stock	F	B	B	$6.20
IMCRImmunocore Holdings plc American Depositary Shares	D	B	B	$37.40
RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	D	C	C	$3.56
VIRVir Biotechnology, Inc. Common Stock	B	B	B	$10.71
INBXInhibrx Biosciences, Inc. Common Stock	D	C	B	$122.72
ALVOAlvotech Ordinary Shares	C	D	B	$5.05
MAZEMaze Therapeutics, Inc. Common Stock	—	—	B	$30.42
NVAXNovavax Inc	B	D	C	$9.44
REPLReplimune Group, Inc.	—	—	A	$15.80
SLBTSL Science Holding Limited Ordinary Shares	—	—	F	$2.64
MGTXMeiraGTx Holdings plc Ordinary Shares	D	C	A	$14.92
VORVor Biopharma Inc. Common Stock	—	—	B	$24.01
CGEMCullinan Therapeutics, Inc. Common Stock	—	—	A	$22.95
IMTXImmatics N.V. Ordinary Shares	C	D	C	$9.24
ODTXOdyssey Therapeutics, Inc. Common Stock	—	C	A	$26.23

About Solid Biosciences Inc. Common Stock

Solid Biosciences is a gene therapy company developing treatments for neuromuscular and cardiac diseases, with a primary focus on Duchenne muscular dystrophy (DMD). The company's pipeline includes SB-001 and other programs spanning corrective therapies, disease-modifying therapies, and assistive devices for genetic muscle-wasting conditions.